Malignant Genitourinary System Neoplasm

Malignant Genitourinary System Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

15,539 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 3,546
Recruiting: 1,932
Ph III recruiting: 225
Growth YoY: +16.4%
Industry share: 22%
Top sponsor: M.D. Anderson Cancer Center
Termination share: 29.7%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (1,963)

clinicaltrialsPublishedShowing 101–150 of 2,541 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT07543055	A Phase 1 Study of BPX-601 CAR T-Cell Therapy in Adult Participants With Prostate Cancer That Has Returned, is Resistant to Treatment and Has Spread	recruiting	Phase 1	36	Regeneron PharmaceuticalsINDUSTRY	1	Sep 24, 2026	clinicaltrials
NCT07594015	Pembrolizumab and Lenvatinib in Mismatch Repair Proficient Recurrent Endometrial Cancer After Progression on or Following First-Line Immunotherapy Maintenance	recruiting	Phase 2	46	University of MiamiOTHER	1	Sep 24, 2026